B53.1
Malaria due to simian plasmodia
Clinical Classification Guidelines
Excludes Type 1
- Malaria due to simian plasmodia with Plasmodium falciparum (B50.-)
- Malaria due to simian plasmodia with Plasmodium malariae (B52.-)
- Malaria due to simian plasmodia with Plasmodium ovale (B53.0)
- Malaria due to simian plasmodia with Plasmodium vivax (B51.-)
Medical Intelligence & Overview
Malaria caused by simian plasmodia (B53.1) is a rare type of malaria that occurs when the malaria parasites naturally found in monkeys infect humans. This form of malaria is uncommon but can cause serious health issues if not diagnosed and treated promptly. Typically, this type of malaria involves specific species of Plasmodium that usually infect non-human primates, but under certain circumstances, they can be transmitted to humans, leading to illness. Understanding how this disease occurs, its symptoms, and available approaches to diagnosis and management can help increase awareness and facilitate early recognition.
Causes & Symptoms
Clinical Causes: Transmission of simian plasmodia from infected monkeys to humans via mosquito bites, particularly Anopheles mosquitoes that feed on both non-human primates and humans. Environmental factors such as proximity to forests or wildlife habitats where infected primates are present. Travel to regions where simian malaria is prevalent or where humans are likely to encounter infected mosquitoes. Potential zoonotic transmission due to close contact with infected animals or their blood, although this is less common than vector-borne transmission.
Key Symptoms: Fever that may come and go in cycles Chills and sweating episodes Headache and fatigue Muscle aches and joint pain Nausea or vomiting Possible gastrointestinal discomfort Anemia or weakness in more severe cases Rarely, complications such as organ failure if left untreated
Diagnostic & Treatment
Diagnosis Path: Microscopic examination of blood smears to identify the specific Plasmodium species present Rapid diagnostic tests (RDTs) that detect malaria antigens, although these may have limitations with rare strains Polymerase chain reaction (PCR) testing for more accurate species identification, especially in atypical cases Patient history review focusing on travel, animal exposure, and symptom chronology
Treatment Protocols: Chloroquine (where resistance is not an issue) Artemisinin-based combination therapies (ACTs) for more resistant infections Supportive care to manage symptoms like fever and dehydration Monitoring and follow-up to ensure parasite clearance and prevent relapse
Clinical Advice & FAQs
Billing Guidance
Is B53.1 a billable ICD-10 code?
Yes, B53.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B53.1?
Clinical documentation must specify the nature of Malaria due to simian plasmodia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference